Discover why Abbott Laboratories (ABT) earns a buy rating with strong fundamentals, dividend growth, and growth prospects.

If you have been wondering whether Abbott Laboratories is still a buy at around $125 a share, you are not alone. This is exactly the kind of stock where valuation really matters. Despite slipping ...

The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...

The latest announcement is out from Exact Sciences ( (EXAS) ).

San Diego police only provide the device to certified drug recognition experts, who say it’s a great tool, but also the last ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

North Texas school districts must find creative ways to fulfill the needs to the special education students while state ...

If you have $50,000 to invest right now, you could choose to diversify that capital across a handful of different businesses.

One of the main threads running through our most-read stories of 2025—as much as ever in the medtech industry writ large—is ...

Abbott Laboratories (ABT), the global healthcare titan, announced on Dec. 22 that the U.S. Food and Drug Administration (FDA) ...

Starbase has filed at least four lawsuits against the Texas Attorney General’s Office over its rulings that information ...